Private Capital Group, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$7,000
-12.5%
2300.0%0.01%
+150.0%
Q1 2022$8,000
+700.0%
230
+721.4%
0.00%
Q4 2021$1,000
-80.0%
28
-75.2%
0.00%
-100.0%
Q3 2021$5,000
-72.2%
113
-65.1%
0.00%
-75.0%
Q2 2021$18,000
-55.0%
324
-39.0%
0.00%
-60.0%
Q1 2021$40,000
+185.7%
531
+236.1%
0.01%
+233.3%
Q4 2020$14,000
+55.6%
158
+1.9%
0.00%
+50.0%
Q3 2020$9,000
+200.0%
155
+101.3%
0.00%
+100.0%
Q2 2020$3,0000.0%77
-32.5%
0.00%0.0%
Q1 2020$3,000
+200.0%
114
+470.0%
0.00%
Q4 2019$1,000
-93.8%
20
-82.6%
0.00%
-100.0%
Q3 2019$16,0001150.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders